Plasma colchicine concentration in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis.

作者信息

Katz E Z, Ehrenfeld M, Levy M, Eliakim M

出版信息

Arthritis Rheum. 1982 Feb;25(2):227-31. doi: 10.1002/art.1780250219.

DOI:10.1002/art.1780250219

PMID:7066054

Abstract

摘要

相似文献

Plasma colchicine concentration in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis.

Arthritis Rheum. 1982 Feb;25(2):227-31. doi: 10.1002/art.1780250219.

Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever).

Am J Med Sci. 1981 Jan-Feb;281(1):15-8. doi: 10.1097/00000441-198101000-00002.

Long-term colchicine therapy of familial Mediterranean fever.

J Pediatr. 1978 Nov;93(5):876-8. doi: 10.1016/s0022-3476(78)81107-x.

Colchicine concentration in leukocytes of patients with familial Mediterranean fever.

Br J Clin Pharmacol. 1994 Jul;38(1):87-9. doi: 10.1111/j.1365-2125.1994.tb04328.x.

The effect of long-term colchicine therapy in patients with recurrent polyserositis on the capacity of blood platelets to synthesize thromboxane A2.

Br J Clin Pharmacol. 1983 Aug;16(2):191-4. doi: 10.1111/j.1365-2125.1983.tb04985.x.

Letter: Colchicine-aspirin for recurrent polyserositis (familial Mediterranean fever).

Lancet. 1973 Dec 8;2(7841):1333. doi: 10.1016/s0140-6736(73)92915-2.

Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis).

J Pediatr. 1990 Jun;116(6):997-9. doi: 10.1016/s0022-3476(05)80667-5.

Colchicine treatment in familial Mediterranean fever: an indirect effect on in vitro serum amyloid A secretion via leukocyte derived factors.

Clin Exp Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S76.

Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement.

Pediatrics. 2007 Feb;119(2):e474-83. doi: 10.1542/peds.2006-1434. Epub 2007 Jan 22.

[Colchicine (problems of its pharmacokinetics, mechanism of action and use in therapeutic practice)].

Revmatologiia (Mosk). 1985 Apr-Jun(2):61-4.

引用本文的文献

The Influence of Patient Factors on the Population Pharmacokinetics of Colchicine: Implications for Safe and Effective Dosing.

Clin Pharmacokinet. 2025 Oct;64(10):1517-1529. doi: 10.1007/s40262-025-01551-y. Epub 2025 Jul 28.

Colchicine's Role in Cardiovascular Disease Management.

Arterioscler Thromb Vasc Biol. 2024 May;44(5):1031-1041. doi: 10.1161/ATVBAHA.124.319851. Epub 2024 Mar 21.

Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?

Rheumatol Int. 2020 Jan;40(1):129-135. doi: 10.1007/s00296-019-04432-3. Epub 2019 Aug 28.

Colchicine concentration in leukocytes of patients with familial Mediterranean fever.

Br J Clin Pharmacol. 1994 Jul;38(1):87-9. doi: 10.1111/j.1365-2125.1994.tb04328.x.

The effect of long-term colchicine therapy in patients with recurrent polyserositis on the capacity of blood platelets to synthesize thromboxane A2.

Br J Clin Pharmacol. 1983 Aug;16(2):191-4. doi: 10.1111/j.1365-2125.1983.tb04985.x.

Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial mediterranean fever).

Dig Dis Sci. 1982 Aug;27(8):723-7. doi: 10.1007/BF01393768.

Pharmacokinetics/bioavailability of colchicine in healthy male volunteers.

Eur J Drug Metab Pharmacokinet. 1989 Oct-Dec;14(4):317-22. doi: 10.1007/BF03190118.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验